H Chamberlin
Impact in
-
- Histone Deacetylase Inhibitors Research
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
- Signaling Pathways in Disease
- Genomics and Chromatin Dynamics
-
- Peptidase Inhibition and Analysis
- Cancer-related Molecular Pathways
Papers in
-
- Retinoids in leukemia and cellular processes 2
- Histone Deacetylase Inhibitors Research 1
- Biochemical and Molecular Research 1
- Plant biochemistry and biosynthesis 1
- Oncology 2
- Cancer Treatment and Pharmacology 1
- Cancer-related Molecular Pathways 1
- Co-authors
- Dalia Cohen (2 shared papers)Hong Xu (1 shared paper)Lidia Sambucetti (1 shared paper)Sonya Zabludoff (1 shared paper)Paul Kwon (1 shared paper)Jamison L. Nourse (1 shared paper)David O. Morgan (1 shared paper)Jin Pei (1 shared paper)
- Journals
- Archives of Biochemistry and Biophysics (1 paper)International Journal of Oncology (1 paper)Biochemical Pharmacology (1 paper)Journal of Biological Chemistry (1 paper)Blood (1 paper)
- Partner nations
- United StatesRussiaSwitzerland
In The Last Decade
H Chamberlin
7 papers receiving 418 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 387
- Oncology 113
- Cancer Research 29
- Toxicology 5
- Hematology 16
Countries citing papers authored by H Chamberlin
This map shows the geographic impact of H Chamberlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Chamberlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Chamberlin more than expected).
Fields of papers citing papers by H Chamberlin
This network shows the impact of papers produced by H Chamberlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Chamberlin. The network helps show where H Chamberlin may publish in the future.
Co-authors
The 15 scholars most cited alongside H Chamberlin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 349 | |
| 2 | Control of eukaryotic cell cycle progression by phosphorylation of cyclin-dependent kinases. | 1998 | 32 |
| 3 | 1995 | 19 | |
| 4 | 1991 | 15 | |
| 5 | 1999 | 13 | |
| 6 | 1990 | 4 | |
| 7 | Dimethyl sulfoxide inhibits the binding of granulocyte/macrophage colony-stimulating factor and insulin to their receptors on human leukemia cells. | 1993 | 2 |
About H Chamberlin
H Chamberlin is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Organic Chemistry and Cellular and Molecular Neuroscience, having authored 7 papers that have together received 434 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (2 papers), Cancer Treatment and Pharmacology (1 paper), Cytomegalovirus and herpesvirus research (1 paper), Histone Deacetylase Inhibitors Research (1 paper), Biochemical and Molecular Research (1 paper), Cancer-related Molecular Pathways (1 paper), Acute Myeloid Leukemia Research (1 paper) and Plant biochemistry and biosynthesis (1 paper). The work is most often cited by research in Molecular Biology (387 citations), Oncology (113 citations), Cancer Research (29 citations), Toxicology (5 citations) and Hematology (16 citations). H Chamberlin has collaborated with scholars based in United States, Russia and Switzerland. Frequent co-authors include Dalia Cohen, Hong Xu, Lidia Sambucetti, Sonya Zabludoff, Paul Kwon, Jamison L. Nourse, David O. Morgan, Jin Pei, Stuart L. Emanuel and Edward L. Schwartz. Their work appears in journals such as Archives of Biochemistry and Biophysics, International Journal of Oncology, Biochemical Pharmacology, Journal of Biological Chemistry and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.